Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulka Vaishampayan

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Current Oncology Reports|January 8, 2013
Cabozantinib as a novel therapy for renal cell carcinomaUlka Vaishampayan
Current Treatment Options in Oncology|May 2, 2009
Systemic therapy of advanced urothelial cancerUlka Vaishampayan
Current Opinion in Oncology|March 15, 2014
Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancerUlka Vaishampayan
Current Treatment Options in Oncology|January 26, 2018
Evolving Treatment Paradigms in Non-clear Cell Kidney CancerUlka Vaishampayan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2018
Advantages and Adversities of the Weighted Toxicity ScoreUlka Vaishampayan
Urologic Oncology|February 19, 2004
PSA relapse prostate cancer: the importance of tailored therapyOlivia Aranha, Ulka Vaishampayan
Current Oncology Reports|February 13, 2020
Current State of Systemic Therapies for Advanced Renal Cell CarcinomaShuchi Gulati, Ulka Vaishampayan
Targeted Oncology|December 12, 2018
Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of TreatmentHarsh Shah, Ulka Vaishampayan
Journal of Kidney Cancer and VHL|July 7, 2025
Hypoxia Inducible Factor-2α (HIF-2α) Pathway InhibitorsRatika Dogra, Ulka Vaishampayan
Critical Reviews in Oncology/Hematology|May 15, 2002
The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st centuryUlka Vaishampayan, Maha Hussain
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Current Oncology Reports|January 8, 2013
Cabozantinib as a novel therapy for renal cell carcinomaUlka Vaishampayan
Current Treatment Options in Oncology|May 2, 2009
Systemic therapy of advanced urothelial cancerUlka Vaishampayan
Current Opinion in Oncology|March 15, 2014
Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancerUlka Vaishampayan
Current Treatment Options in Oncology|January 26, 2018
Evolving Treatment Paradigms in Non-clear Cell Kidney CancerUlka Vaishampayan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2018
Advantages and Adversities of the Weighted Toxicity ScoreUlka Vaishampayan
Urologic Oncology|February 19, 2004
PSA relapse prostate cancer: the importance of tailored therapyOlivia Aranha, Ulka Vaishampayan
Current Oncology Reports|February 13, 2020
Current State of Systemic Therapies for Advanced Renal Cell CarcinomaShuchi Gulati, Ulka Vaishampayan
Targeted Oncology|December 12, 2018
Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of TreatmentHarsh Shah, Ulka Vaishampayan
Journal of Kidney Cancer and VHL|July 7, 2025
Hypoxia Inducible Factor-2α (HIF-2α) Pathway InhibitorsRatika Dogra, Ulka Vaishampayan
Critical Reviews in Oncology/Hematology|May 15, 2002
The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st centuryUlka Vaishampayan, Maha Hussain
Pageof 18